HIGHLIGHTS
- who: Laura Vanderwaeren and collaborators from the Laboratory of Experimental Radiotherapy, Department of Oncology, KU, BelgiumDepartment of Radiation Oncology, Cancer Institute, University Hospitals have published the research work: Clinical Progress in Proton Radiotherapy: Biological Unknowns, in the Journal: Cancers 2021, 13, 604. of /2021/
- what: The main reason for this is the beneficial depth-dose distribution of protons that allows to reduce toxicity to normal tissues surrounding the tumor. Now, with the 3 of 16 increasing amount of proton therapy facilities with integrated radiobiological research centers, more and more radiobiological research is focused towards protons . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.